Radirif®

Nalbuphine HCl
Non-narcotic analgesic (CNS Preparations)

Indication:
Moderate to severe pain, moderate to severe pain associated with myocardial infarction (MI), as a supplement to balanced anesthesia, for preoperative and postoperative analgesia and for obstetrical analgesia during labor and delivery.

Dosage & Administration:
The usual recommended adult dose is 10 mg for a 70 kg individual, administered subcutaneously, intramuscularly or intravenously; this dose may be repeated every 3 to 6 hours as necessary. Dosage should be adjusted according to the severit

Preparation:
 Radirif® 2 injection: Each box contains 4 ampoules in blister pack with sterile disposable syringe.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides